Does RUCAPARIB CAMSYLATE Cause Therapy partial responder? 136 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 136 reports of Therapy partial responder have been filed in association with RUCAPARIB CAMSYLATE (Rubraca). This represents 1.7% of all adverse event reports for RUCAPARIB CAMSYLATE.
136
Reports of Therapy partial responder with RUCAPARIB CAMSYLATE
1.7%
of all RUCAPARIB CAMSYLATE reports
2
Deaths
17
Hospitalizations
How Dangerous Is Therapy partial responder From RUCAPARIB CAMSYLATE?
Of the 136 reports, 2 (1.5%) resulted in death, 17 (12.5%) required hospitalization.
Is Therapy partial responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUCAPARIB CAMSYLATE. However, 136 reports have been filed with the FAERS database.
What Other Side Effects Does RUCAPARIB CAMSYLATE Cause?
Fatigue (2,494)
Nausea (2,219)
Malignant neoplasm progression (1,162)
Decreased appetite (787)
Constipation (763)
Diarrhoea (759)
Vomiting (759)
Asthenia (660)
Adverse event (571)
Carbohydrate antigen 125 increased (562)
What Other Drugs Cause Therapy partial responder?
CYCLOPHOSPHAMIDE (1,397)
RITUXIMAB (1,219)
DEXAMETHASONE (1,199)
PREDNISONE (1,176)
PEMBROLIZUMAB (1,125)
CARBOPLATIN (1,096)
DOXORUBICIN (834)
METHOTREXATE (775)
VINCRISTINE (707)
ETOPOSIDE (670)
Which RUCAPARIB CAMSYLATE Alternatives Have Lower Therapy partial responder Risk?
RUCAPARIB CAMSYLATE vs RUFINAMIDE
RUCAPARIB CAMSYLATE vs RUPATADINE
RUCAPARIB CAMSYLATE vs RUXOLITINIB
RUCAPARIB CAMSYLATE vs SABRIL
RUCAPARIB CAMSYLATE vs SACCHAROMYCES CEREVISIAE